Yunfei Yuan

researcher

Yunfei Yuan is …
instance of (P31):
humanQ5

External links are
P496ORCID iD0000-0003-2467-3683
P1153Scopus author ID7402708979

P734family nameYuanQ716212
YuanQ716212
YuanQ716212
P735given nameYunfeiQ8061244
YunfeiQ8061244
P106occupationresearcherQ1650915

Reverse relations

author (P50)
Q28292754A disrupted RNA editing balance mediated by ADARs (Adenosine DeAminases that act on RNA) in human hepatocellular carcinoma
Q39949546A functional polymorphism in the miR-146a gene is associated with the risk for hepatocellular carcinoma.
Q37353932A modified radiofrequency ablation approach for treating distant lymph node metastasis in two patients with late-stage cancer
Q34147202A novel GSK-3 beta-C/EBP alpha-miR-122-insulin-like growth factor 1 receptor regulatory circuitry in human hepatocellular carcinoma
Q47443711A novel functional polymorphism in the Cdc6 promoter is associated with the risk for hepatocellular carcinoma
Q86822496A novel vascular pattern promotes metastasis of hepatocellular carcinoma in an epithelial-mesenchymal transition-independent manner
Q41152266A serum microRNA classifier for early detection of hepatocellular carcinoma: a multicentre, retrospective, longitudinal biomarker identification study with a nested case-control study.
Q36200984ANXA3/JNK Signaling Promotes Self-Renewal and Tumor Growth, and Its Blockade Provides a Therapeutic Target for Hepatocellular Carcinoma.
Q39034955Allele-specific imbalance of oxidative stress-induced growth inhibitor 1 associates with progression of hepatocellular carcinoma.
Q33711636Application of tumor-node-metastasis staging 2002 version in locally advanced hepatocellular carcinoma: is it predictive of surgical outcome?
Q89535408Author response to Letter to the Editor: 'Are inflammation-based models feasible tools in predicting the outcome of patients with hepatocellular carcinoma?'
Q37226458Bevacizumab with preoperative chemotherapy versus preoperative chemotherapy alone for colorectal cancer liver metastases: a retrospective cohort study
Q33755370CHD1L promotes hepatocellular carcinoma progression and metastasis in mice and is associated with these processes in human patients.
Q50518741CHD1L promotes lineage reversion of hepatocellular carcinoma through opening chromatin for key developmental transcription factors.
Q36659343CHK1 targets spleen tyrosine kinase (L) for proteolysis in hepatocellular carcinoma.
Q45366225Changes in hepatitis B virus DNA levels and liver function after transcatheter arterial chemoembolization of hepatocellular carcinoma.
Q38314621Characterization of the oncogenic function of centromere protein F in hepatocellular carcinoma.
Q87165954Checkpoint kinase 1 is negatively regulated by miR-497 in hepatocellular carcinoma
Q87021317Clinical significance and prognostic value of microRNA expression signatures in hepatocellular carcinoma
Q45371340Clinical significance of CHD1L in hepatocellular carcinoma and therapeutic potentials of virus-mediated CHD1L depletion.
Q45702387Clinicopathologic features and long-term outcomes of Chinese patients with hepatocellular carcinoma in non-cirrhotic liver
Q90943573Comparison of the prognostic value of inflammation-based scores in early recurrent hepatocellular carcinoma after hepatectomy
Q40389253CpG Methylation Signature Predicts Recurrence in Early-Stage Hepatocellular Carcinoma: Results From a Multicenter Study
Q54444216CpG island methylator phenotype associated with tumor recurrence in tumor-node-metastasis stage I hepatocellular carcinoma.
Q120156331Dysregulation of PLOD2 Promotes Tumor Metastasis and Invasion in Hepatocellular Carcinoma
Q45352662Effects of antiviral therapy on hepatitis B virus reactivation and liver function after resection or chemoembolization for hepatocellular carcinoma.
Q86307530Efficacy and safety of thermal ablation in patients with liver metastases
Q39358186Expression and prognostic significance of CIP2A mRNA in hepatocellular carcinoma and nontumoral liver tissues.
Q37646934Expression of variant isoforms of the tyrosine kinase SYK determines the prognosis of hepatocellular carcinoma.
Q43413375Genome-wide association study identifies 1p36.22 as a new susceptibility locus for hepatocellular carcinoma in chronic hepatitis B virus carriers
Q85741755HBP21, a chaperone of heat shock protein 70, functions as a tumor suppressor in hepatocellular carcinoma
Q86485800Hepatectomy Versus Hepatectomy With Lymphadenectomy in Hepatocellular Carcinoma: A Prospective, Randomized Controlled Clinical Trial
Q45749941Hepatectomy for hepatocellular carcinoma patients with macronodular cirrhosis
Q45383669Hepatic resection for synchronous hepatic metastasis from gastric cancer.
Q40548381High preoperative serum CA19-9 level is predictive of poor prognosis for patients with colorectal liver oligometastases undergoing hepatic resection
Q34561185Identification of medium-sized genomic deletions with low coverage, mate-paired restricted tags
Q59799844Impact of follow-up interval on patients with hepatocellular carcinoma after curative ablation
Q36121202Impact of oral anti-hepatitis B therapy on the survival of patients with hepatocellular carcinoma initially treated with chemoembolization
Q33961542Interleukin 17A promotes hepatocellular carcinoma metastasis via NF-kB induced matrix metalloproteinases 2 and 9 expression.
Q34438689Interleukin 23 promotes hepatocellular carcinoma metastasis via NF-kappa B induced matrix metalloproteinase 9 expression
Q33812222LOH analysis of genes around D4S2964 identifies ARD1B as a prognostic predictor of hepatocellular carcinoma
Q45399492Large-scale analysis of the genetic and epigenetic alterations in hepatocellular carcinoma from Southeast China.
Q93387660Letter: is microwave ablation superior to radiofrequency ablation for early stage hepatocellular carcinoma? Authors' reply
Q57455124Letter: microwave vs radiofrequency ablation for hepatocellular carcinoma within the Milan criteria-Authors' reply
Q38719518Lidocaine Induces Apoptosis and Suppresses Tumor Growth in Human Hepatocellular Carcinoma Cells In Vitro and in a Xenograft Model In Vivo.
Q93143861Lipiodol deposition in portal vein tumour thrombus predicts treatment outcome in HCC patients after transarterial chemoembolisation
Q43240643Liver cancer: EphrinA2 promotes tumorigenicity through Rac1/Akt/NF-kappaB signaling pathway
Q39365871Liver hypertrophy and accelerated growth of implanted tumors in nonembolized liver of rabbit after left portal vein embolization.
Q88761252Long- versus short-interval follow-up after resection of hepatocellular carcinoma: a retrospective cohort study
Q45010628Long-term outcomes and prognostic factors of elderly patients with hepatocellular carcinoma undergoing hepatectomy
Q47869237Long-term survival after resection of hepatocelluar carcinoma: a potential risk associated with the choice of postoperative analgesia
Q38861160Loss of ATOH8 Increases Stem Cell Features of Hepatocellular Carcinoma Cells
Q34745477MACC1 as a prognostic biomarker for early-stage and AFP-normal hepatocellular carcinoma
Q47821487Maelstrom promotes hepatocellular carcinoma metastasis by inducing epithelial-mesenchymal transition by way of Akt/GSK-3β/Snail signaling.
Q39309630MicroRNA-125b promotes apoptosis by regulating the expression of Mcl-1, Bcl-w and IL-6R.
Q54191926MicroRNA-130a is down-regulated in hepatocellular carcinoma and associates with poor prognosis.
Q39184127MicroRNA-195 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting the expression of VEGF, VAV2, and CDC42.
Q40536884MicroRNAs miR-125b and miR-100 suppress metastasis of hepatocellular carcinoma by disrupting the formation of vessels that encapsulate tumour clusters.
Q90532946Microwave ablation versus resection for hepatocellular carcinoma within the Milan criteria: a propensity-score analysis
Q90659238Microwave vs radiofrequency ablation for hepatocellular carcinoma within the Milan criteria: a propensity score analysis
Q33702300Mutual Regulation of MiR-199a-5p and HIF-1α Modulates the Warburg Effect in Hepatocellular Carcinoma.
Q39474147NADPH oxidase DUOX1 and DUOX2 but not NOX4 are independent predictors in hepatocellular carcinoma after hepatectomy.
Q40775158Nomograms for Pre- and Postoperative Prediction of Long-term Survival for Patients Who Underwent Hepatectomy for Multiple Hepatocellular Carcinomas
Q38503687Novel therapeutic potential in targeting microtubules by nanoparticle albumin-bound paclitaxel in hepatocellular carcinoma.
Q48273193Octamer 4/microRNA-1246 signaling axis drives Wnt/β-catenin activation in liver cancer stem cells.
Q97533883PIM2 promotes hepatocellular carcinoma tumorigenesis and progression through activating NF-κB signaling pathway
Q34517592Partial hepatectomy for liver metastases from nasopharyngeal carcinoma: a comparative study and review of the literature
Q53153527Percutaneous microwave ablation of larger hepatocellular carcinoma.
Q85303207Phase I trial of hepatic arterial infusion (HAI) of floxuridine with modified oxaliplatin, 5-fluorouracil and leucovorin (m-FOLFOX6) in Chinese patients with unresectable liver metastases from colorectal cancer
Q39635505Prognostic value of Wnt inhibitory factor-1 expression in hepatocellular carcinoma that is independent of gene methylation.
Q71699166Randomized study of chemoembolization as an adjuvant therapy for primary liver carcinoma after hepatectomy
Q45083949Reactivation of SYK expression by inhibition of DNA methylation suppresses breast cancer cell invasiveness
Q41750292Resection versus ablation in hepatitis B virus-related hepatocellular carcinoma patients with portal hypertension: A propensity score matching study.
Q53756810Response to Ablation and resection for hepatocellular carcinoma within the Milan criteria and high alpha-fetoprotein levels.
Q39581200Role of Sox2 and Oct4 in predicting survival of hepatocellular carcinoma patients after hepatectomy.
Q53263915SPOCK1 is regulated by CHD1L and blocks apoptosis and promotes HCC cell invasiveness and metastasis in mice.
Q36916295Safety and efficacy of sorafenib therapy in patients with hepatocellular carcinoma: final outcome from the Chinese patient subset of the GIDEON study.
Q39409326Serum and glucocorticoid kinase 3 at 8q13.1 promotes cell proliferation and survival in hepatocellular carcinoma.
Q37701106Sorafenib therapy following resection prolongs disease-free survival in patients with advanced hepatocellular carcinoma at a high risk of recurrence
Q27311589Systemic delivery of microRNA-101 potently inhibits hepatocellular carcinoma in vivo by repressing multiple targets
Q36237549TGF-β-miR-34a-CCL22 signaling-induced Treg cell recruitment promotes venous metastases of HBV-positive hepatocellular carcinoma.
Q33776697The Role of Adjuvant Chemotherapy for Colorectal Liver Metastasectomy after Pre-Operative Chemotherapy: Is the Treatment Worthwhile?
Q39347890The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection.
Q35441132The role of clinically significant portal hypertension in hepatic resection for hepatocellular carcinoma patients: a propensity score matching analysis
Q95655738Transcatheter arterial chemoembolization alone or combined with ablation for recurrent intermediate-stage hepatocellular carcinoma: a propensity score matching study
Q53216551Translationally controlled tumor protein induces mitotic defects and chromosome missegregation in hepatocellular carcinoma development.
Q34667439Upregulation of microRNA-106b is associated with poor prognosis in hepatocellular carcinoma

Search more.